Specific factor Xa (FXa) inhibitors.*
| * Partial list of factor Xa inhibitors available or in development |
| Indirect (Antithrombin-Dependent) FXa Inhibitors |
| fondaparinux (Arixtra®) [GlaxoSmithKline] - parenteral |
| idraparinux [Sanofi-Synthelabo] - parenteral |
| Direct (Antithrombin-Independent) FXa Inhibitors |
| BAY 59-7939 [Bayer] – oral |
| DPC-423 [Bristol-Myers Squibb] – oral |
| DX-9065a [Daiichi] – parenteral/oral |
| LY517717 [Lilly] – oral |
| Razaxaban (DPC906) [Bristol-Myers Squibb] – oral |
| * Partial list of factor Xa inhibitors available or in development |
| Indirect (Antithrombin-Dependent) FXa Inhibitors |
| fondaparinux (Arixtra®) [GlaxoSmithKline] - parenteral |
| idraparinux [Sanofi-Synthelabo] - parenteral |
| Direct (Antithrombin-Independent) FXa Inhibitors |
| BAY 59-7939 [Bayer] – oral |
| DPC-423 [Bristol-Myers Squibb] – oral |
| DX-9065a [Daiichi] – parenteral/oral |
| LY517717 [Lilly] – oral |
| Razaxaban (DPC906) [Bristol-Myers Squibb] – oral |